Radiofrequency ablation of liver cancer: Early evaluation of therapeutic response with contrast-enhanced ultrasonography

Korean Journal of Radiology

Volumn 5, Issue 3, 2004, Pages 185-198

  Choi, Dongil ^a   Lim, Hyo K ^a   Lee, Won Jae ^a   Kim, Seung Hoon ^a   Kim, Min Ju ^a   Kim, Seung Kwon ^a   Jang, Kyung Mi ^a   Lee, Ji Yeon ^a   Lim, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Liver neoplasms, US; Liver, interventional procedure; Radiofrequency (RF) ablation; Ultrasound (US), contrast media

Indexed keywords

CONTRAST MEDIUM; SH U 508A; UNCLASSIFIED DRUG;

CATHETER ABLATION; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DECISION MAKING; DOPPLER FLOWMETRY; EVALUATION; EXPERIMENT; HUMAN; LITERATURE; LIVER CANCER; MAJOR CLINICAL STUDY; RELIABILITY; REVIEW; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

EID: 7244239088     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2004.5.3.185     Document Type: Review

References (24)

1. Dodd GD 3rd, Soulen MC, Kane RA, et al. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. RadioGraphics 2000;20:9-27
2. Livraghi T, Goldberg SN, Lazzarni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-661
3. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000;217:633-646
4. Lim HK. Radiofrequency thermal ablation of hepatocellular carcinomas. Korean J Radiol 2000;1:175-184
5. McGahan JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001;176:3-16
6. Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002;223: 331-337
7. Lim HK, Choi D, Lee WJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001;221:447-454
8. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent-early experience. Radiology 1999;211:643-649
9. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000;217:558-563
10. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 2001;177:375-380
11. Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003;181:57-63
12. Choi D, Lim HK, Kim SH, et al. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radiofrequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J Ultrasound Med 2002;21:391-401
13. Youk JH, Lee JM, Kim JS. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging. J Ultrasound Med 2003;22:911-920
14. Choi D, Lim HK, Lee WJ, et al. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 2003;22:1163-1172
15. Goldberg SN, Charboneau JW, Dodd GD 3rd, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003;228:335-345
16. Jang HJ, Lim HK, Lee WJ, Kim SH, Kim KA, Kim EY. Ultrasonographic evaluation of focal hepatic lesions: comparison of pulse inversion harmonic, tissue harmonic, and conventional imaging techniques. J Ultrasound Med 2000;19:293-299
17. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000;35:58-71
18. Lee JY, Choi BI, Han JK, Kim AY, Shin SH, Moon SG. Improved sonographic imaging of hepatic hemangioma with contrast-enhanced coded harmonic angiography: comparison with MR imaging. Ultrasound Med Biol 2002;28:287-295
19. Kim JH, Kim TK, Kim BS, et al. Enhancement of hepatic hemangiomas with Levovist on coded harmonic angiographic ultrasonography. J Ultrasound Med 2002;21:141-148
20. Jang HJ, Lim HK, Lee WJ, et al. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US. Korean J Radiol 2003;4:117-123
21. Choi BI, Kim AY, Lee JY, et al. Hepatocellular carcinoma: contrast enhancement with Levovist. J Ultrasound Med 2002;21:77-84
22. Goldberg SN, Gazelle GS, Solbiati L, et al. Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 1998;170:1023-1028
23. Numata K, Isozaki T, Ozawa Y, et al. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. AJR Am J Roentgenol 2003;180:143-149
24. Leen E, Angerson WJ, Yarmenitis S, et al. Multi-center clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions. Eur J Radiol 2002;41:200-206